Financial intelligence for Asia's healthcare markets
Remember me:

News articles    

Chularat Hospital, which operates 13 clinics and hospitals in Thailand, intends to build the Suvarnabhumi Cancer and Radiologist Center Hospital, which will provide specialised medical services to general patients and counterparties in Samutprakan and nearby provinces.
Thomson Medical Group (TMG), Singapore’s second largest healthcare group, has reported EBITDA of S$23.4 million (US$17.1 million) on the back of total revenue for the first half of the year at S$105.5 million.
Healthcare services group Clearbridge Health has reported revenue of S$1.46 million (US$1.1 million) for the three months ended 30 June 2018. The topline growth is nearly four times the S$0.38 million achieved by the group in Q1 and mainly attributed to recent acquisitions including a medical centre in the Philippines in January and in Singapore and Indonesia in April.
Australian hearing implant manufacturer Cochlear delivered net profit of A$245.8 million, an increase of 10% on FY17, which was within the guidance range of A$240-250 million. Chief executive and president Dig Howitt said, “Cochlear continues to deliver on its objective of delivering consistent revenue and earnings growth over time.
Shareholders of Fortis Healthcare, the country’s second largest private hospital chain, have approved the US$584.1 million acquisition plan by IHH Healthcare, Asia’s largest healthcare company – 99.7% voted in favour of the deal.
Retirement village operator Summerset Group Holdings has announced an underlying profit of NZ$45.2 million (US$29.7 million), an increase of 27%, in line with the profit guidance provided in early July.
Leading fully integrated plasma-based biopharmaceutical company China Biologic Products Holdings has appointed Bing Li as chief executive officer. By assuming the CEO position, Li has moved from an independent director to an executive director of the board. Zhijun Tong, the former acting CEO, will continue to serve as an executive director of the board and president of the company.
Beijing-based paediatric healthcare provider New Century Healthcare has taken a 10.1% stake in Chiron Healthcare. Financial terms have not been disclosed.
Private specialist healthcare provider Singapore Medical Group has announced its financial results for the second quarter ended 30 June 2018. Driven by organic growth across newly acquired clinics, the group’s revenue surged 29.9% year-on-year to S$21.6 million (US$15.7 million).
Edward Byrne will retire from the board of Australian hearing implant manufacturer Cochlear at the end of the next annual general meeting which will be held on 16 October. Byrne joined the board in 2002 and has served as the chairman of the company’s medical science committee, as well as on the nomination and technology & innovation committees.

Subscribe to our news RSS feed Get the RSS for HealthInvestor Asia




Singapore-based Novena Global Lifecare Group, one of Asia’s largest and fastest-growing integrated medical healthcare and aesthetic groups, has delayed plans for an IPO. Last year it announced plans to raise US$150 million through a listing on the Taiwan Stock Exchange to expand regionally in North Asia both organically and through acquisitions. In July, it signed an MoU with Korea’s Yozma BioScience Holdings to commercialise its technology and make investments in startups together.



HealthInvestor Asia twitter feed


HealthInvestor UK